OKYO Pharma Limited is a biotechnology company focused on developing innovative therapies for inflammatory and pain-related conditions

The company is engaged in the research and clinical development of novel drug candidates that leverage its proprietary technologies to address unmet medical needs. By targeting specific biological pathways and mechanisms, OKYO aims to create effective treatments for various diseases, including those that affect the eyes and respiratory system, ultimately improving patient outcomes and quality of life. With a commitment to advancing scientific knowledge and fostering collaboration within the healthcare community, OKYO is positioned at the forefront of therapeutic innovation.